Abstract
Influenza is essentially an uncontrolled disease. The effect of current vaccination programs on morbidity is insignificant, and that on mortality marginal. Although effective artificial immunization against influenza was demonstrated soon after the first isolation of the virus from man (Chenoweth et al., 1936), the antigenic variability of the virus has hampered vaccine production and precluded effective control (Table 11–1). The transient protection afforded by presently available inactivated virus vaccines is related, in part, to a rapid decline in vaccine-induced homologous antibody but also to vaccine obsolescence as the result of continuous viral mutation to antigens unlike or less like those of viral predecessors contained in the vaccine (Kilbourne, 1978).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allan, W. H., Madeley, C. R., and Kendal, A. P., 1971, Studies with avian influenza A viruses: Cross protection experiments in chickens, J. Gen. Virol 12:79–84.
Anderson, R. M., and May, R. M., 1985, Vaccination and herd immunity to infectious diseases, Nature 318:323–329.
Anonymous, 1978, Influenza immunization in lupus erythematosus: Safe, effective? Ann. Intern. Med. 88:833–834.
Armerding, D., Rossiter, H., Ghazzouli, I., et al., 1982, Evaluation of live and inactivated influenza A virus vaccines in a mouse model, J. Infect. Dis. 145:320–330.
Atassi, M. Z., and Webster, R. G., 1983, Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin, Proc. Natl. Acad. Sci. U.S.A. 80:840–844.
Baez, M., Palese, P., and Kilbourne, E. D., 1980, Gene composition of high-yielding influenza vaccine strains obtained by recombination,J. Infect. Dis. 141:362–365.
Banks, J., Bevan, C., Fennerty, A., et al., 1985, Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients, Eur. J. Respir. Dis. 66:268–272.
Barker, W. H., and Mullooly, J. P., 1980, Influenza vaccination of elderly persons, J.A.M.A. 244:2547–2549.
Barker, W. H., and Mullooly, J. P., 1982, Pneumonia and influenza deaths during epidemics: Implications for prevention, Arch. Intern. Med. 142:85–89.
Barry, D. W., Mayner, R. E., Hochstein, H. D., et al., 1976a, Comparative trial of influenza vaccines. II. Adverse reactions in children and adults, Am. J. Epidemiol. 104:47–59.
Barry, D. W., Mayner, R. E., Staton, E., et al., 1976b, Comparative trial of influenza vaccines. I. Im-munogenicity of whole virus and split product vaccines in man, Am. J. Epidemiol. 104:34–46.
Baskerville, A., Thomas, G., and Peacock, S., 1975, Pathological aspects of immunization of mice against influenza virus infection, Br. J. Exp. Pathol. 56: 17–27.
Beare, A. S., 1975, Live viruses for immunization against influenza, Prog. Med. Virol. 20:49–83.
Beare, A. S., and Bynoe, M. L., 1969, Attenuation of human influenza A viruses, Br. Med. J. 4:198–201.
Beare, A. S., Bynoe, M. L., and Tyrrell, D. A. J., 1968a, Investigation into the attenuation of influenza viruses by serial passage, Br. Med. J. 4:482–484.
Beare, A. S., Hobson, D., Reed, S. E., et al., 1968b, A comparison of live and killed influenza-virus vaccines, Lancet 2:418–420.
Beare, A. S., Schild, G. C., and Craig, J. W., 1975, Trials in man with live recombinants made from A/PR/8/34 (H0N1) and wild H3N2 influenza viruses, Lancet 2:729–738.
Becht, H., Huang, R. T. C., Fleisher, B., et al., 1984, Immunogenic properties of the small chain HA2 of the haemagglutinin of influenza viruses, J. Gen. Virol. 65:173–183.
Beebe, G. W., Simon, A. H., and Vivona, S., 1964, Follow-up study on army personnel who received adjuvant influenza virus vaccine, 1951–1953, Am. J. Med. Sci. 247:385–406.
Bell, T. D., Chai, H., Berlow, B., et al., 1978, Immunization with killed influenza virus in children with chronic asthma, Chest 73:140–145.
Bennink, J. R., Yewdell, J. W., Smith, G. L., et al., 1984, Recombinant vaccinia virus primes and stimulates influenza hemagglutinin-specific cytotoxic T cells, Nature 311:578–579.
Bernstein, D. I., and Cherry, J. D., 1983, Clinical reactions and antibody responses to influenza vaccines, Am. J. Dis. Child. 137:622–626.
Bernstein, D. I., Zahradnik, J. M., DeAngelis, C. J., et al., 1982, Influenza immunization in children and young adults, Am. J. Dis. Child. 36:513–517.
Betts, R. F., Douglas, R. G., Jr., Roth, F. K., et al., 1977, Efficacy of live attenuated influenza A/Scot-land/74 (H3N2) virus vaccine against challenge with influenza A/Victoria/3/75 (H3N2) virus, J. Infect. Dis. 136:746–753.
Beutner, K. R., Chow, T., Rubi, E., et al., 1979, Evaluation of a neuraminidase-specific influenza A virus vaccine in children: Antibody responses and effects on two successive outbreaks of natural infection, J. Infect. Dis. 140:844–850.
Bierman, C. W., Shapiro, G. G., Pierson, W. E., et al., 1977, Safety of influenza vaccination in allergic children, J. Infect. Dis. 136:S652–S655.
Biro, J., and Beregi, E., 1980, The influence of influenza vaccinations on human peripheral lymphocytes relating to aging, Akt. Gerontol. 10:319–322.
Blumberg, S., Bienfang, D., and Kantrowitz, F. G., 1980, A possible association between influenza vaccination and small-vessel vasculitis, Arch. Intern. Med. 140:847–848.
Boffey, P. M., 1976, Swine flu campaign: Should we vaccinate the pigs? Science 192:870.
Both, G. W., Shi, C. H., and Kilbourne, E. D., 1983, Hemagglutinin of swine influenza virus: A single amino acid change pleiotropically affects viral antigenicity and replication, Proc. Natl. Acad. Sci. U.S.A. 80:6996–7000.
Brooks, R., and Reznik, A., 1980, Guillain-Barre syndrome following trivalent influenza vaccine in an elderly patient, Mt. Sinai J. Med. 47:190–191.
Brown, L. A., Dopheide, T. A. A., Ward, C. W., et al., 1980, Antigenic determinants of influenza virus hemagglutinin. V. Antigenicity of the HA2 chain, J. Immunol. 125:1583–1588.
Bruyn, H. B., Meiklejohn, G., and Brainerd, H. D., 1949, Influenza vaccination: A comparison of antibody response obtained by various methods of administration, J. Immunol. 62:1–11.
Buchner, D. M., Carter, W. B., and Inui, T. S., 1985, The relationship of attitude changes to compliance with influenza immunization, Med. Care 23:771–779.
Budnick, L. D., Stricof, R. L., and Ellis, F., 1984, An outbreak of influenza A in a nursing home, 1982, N.Y. State J. Med. 84:235–238.
Bukowskyj, M., Munt, P. W., Wigle, R., et al., 1984, Theophylline clearance, Am. Rev. Respir. Dis. 129:672–675.
Burlington, D. B., Wright, P. F., van Wyke, K. L., et al., 1985, Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children, J. Clin. Microbiol. 21:847–849.
Burnet, F. M., 1943, Immunization against epidemic influenza with living attenuated virus, Med. J. Aust. 1:385–389.
Buttar, K., Chernesky, M., and Dolovich, J., 1981, Cutaneous responses to tests with influenza vaccines, Ann. Allergy 46:183–188.
Cannata, J., Cuesta, V., Peral, V., et al., 1981, Reactivation of vasculitis after influenza vaccination, Br. Med. J. 83:526.
Caspary, E. A., Currie, S., Walton, J. N., et al., 1971, Lymphocyte sensitization to nervous tissues and muscle in patients with the Guillain-Barre syndrome, J. Neurol. Neurosurg. Psychiatry 34:179–181.
Centers for Disease Control, 1985a, Immunization Practices Advisory Committee, recommendations, Morbid. Mortal. Weekly Rep. 34:262–267.
Centers for Disease Control, 1985b, Implementation of recommendations for influenza control, Morbid. Mortal. Weekly Rep. 34:639–643.
Chenoweth, A., Waltz, A. D., Stokes, J., Jr., et al., 1936, Active immunization with the viruses of human and swine influenza, Am. J. Dis. Child. 52:757–758.
Clark, A., Potter, C. W., Jennings, R., et al., 1983, A comparison of live and inactivated influenza A (H1N1) virus vaccines, J. Hyg. (Camb.) 90:361–370.
Clements, M. L., and Murphy, B. R., 1986, Development and persistence of local systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine, J. Clin. Microbiol. 23:66–72.
Clements, M. L., O’Donnell, S., Levine, M. M., et al., 1983, Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: Role of local antibody in resistance to infection with vaccine virus, Infect. Immun. 40:1044–1051.
Clements, M. L., Betts, R. F., Maassab, H. F., et al., 1984a, Dose response of influenza A/Washing-tonJ897J80 (H3N2) cold-adapted reassortment virus in adult volunteers, J. Infect. Dis. 149:814.
Clements, M. L., Betts, R. F., and Murphy, B. R., 1984b, Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection, Lancet 1:705.
Clements, M. L., Betts, R. F., Tierney, E. L., et al., 1986, Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine, J Clin. Microbiol. 23:73–76.
Cole, P. J., and Molyneux, M. E., 1980, Immunological sensitization of human lymphocytes after influenza vaccination, J Infect. 2:67–77.
Cook, S. D., Dowling, P. C., and Whitaker, J. N., 1970, The Guillain-Barre syndrome, Arch. Neurol. 22:470–474.
Couch, R. B., Douglas, R. G., Fedson, D. S., et al., 1971, Correlated studies of a recombinant influenza-virus vaccine. III. Protection against experimental influenza in man, J. Infect. Dis. 124:473–480.
Couch, R. B., Kasel, J. A., Gerin, J. L., et al., 1974, Induction of partial immunity to influenza by a rieuramirridase-specificvaccine, J Infect. Dis. 129:411–420.
Couch, R. B., Webster, R. G., Kasel, J. A., et al., 1979, Efficacy of purified influenza subunit vaccines and relation to the major antigenic determinants on the hemagglutinin molecule, J. Infect. Dis. 140:553–559.
Cox, N. J., and Kendal, A. P., 1984, Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: Analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers, J. Infect. Dis. 149:194–200.
Cox, N. J., Kendal, A. P., Shilov, A. A., et al., 1985, Comparative studies of A/Leningrad/134/57 wild-type and 47-times passaged cold-adapted mutant influenza viruses: Oligonucleotide mapping and RNA-RNA hybridization studies, J. Gen. Virol. 66:1697–1704.
Crawford, C. R., Jennings, R., Bradford, N., et al., 1982, The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines, Clin. Exp. Immunol. 48:739–746.
Crawford, C. R., Faiza Mukhlis, F. A., Jennings, R., et al., 1984, Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1. Preparation and characterization of disrupted virions, Vaccine 2: 193–198.
Davenport, F. M. 1961, Applied immunology of mineral oil adjuvants, J. Allergy 32:177–189.
Davis, A. R., Bos, T., Ueda, M., et al., 1983, Immune response to human influenza virus hemagglutinin expressed in Escherichia coli, Gene 21:273–284.
Dierckx, J. P., Raindorf, M., and Gillard, C., 1976, Surveillance da la fonction respiratoire chez des sujects souffrant de bronchopathie chronique, vaccines par une souche vivante attenuee de virus grippal (RIT 4025), Acta Tuberc, Pneumon. Belg. 67:23–31.
Dolin, R., Wise, T. G., Mazur, M. H., et al., 1977, Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults, J. Infect. Dis. (Suppl.) 136:435–442.
Dolin, R., Reichman, R. C., Madore, H. P., et al., 1982, A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection, N. Engl J. Med. 307:580–584.
Dowdle, W. R., 1977, The swine flu vaccine program, Am. Soc. Microbiol News 43:243–246.
Dowdle, W. R., Millar, J. D., Schonberger, L. B., et al., 1980, Influenza immunization policies and practices in Japan, J. Infect. Dis. 141:258–264.
Downie, J. C., 1984, A genetic and monoclonal analysis of high-yielding reassortants of influenza A virus used for human vaccines, J. Biol. Stand. 12:101–110.
Dreesman, G. R., and Kennedy, R. C., 1985, Anti-idiotypic antibodies: Implications of internal image-based vaccines for infectious diseases, J. Infect. Dis. 151:761–765.
Dull, W. L., Seria, J., Bloomfield, J., et al., 1980, Effects of influenza vaccination on pulmonary function, Bull Eur. Physiopathol. Respir. 16:655–661.
Dunn, G. F. N., and Wormald, P. J., 1973, Influenza-A Hong-Kong vaccine and the new variant A/ENG/42/72, Lancet 1:95.
Ennis, R. A., Dowdle, W. R., Barry, D. W., et al., 1977a, Endotoxin content and clinical reactivity to influenza vaccines, J. Biol. Stand. 5:165–172.
Ennis, F. A., Mayner, R. E., Barry, D. N., et al., 1977b, Correlation of laboratory studies with clinical responses to A/New Jersey influenza vaccines, J. Infect. Dis. 136:S397–406.
Ennis, F. A., Yi-Hua, Q., and Schild, G. C., 1982, Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines, J. Gen. Virol 58:273–281.
Erickson, A. H., 1977, Different trypsin-sensitivity of the hemagglutinin from antigenically similar recombinant influenza vaccines, Doctoral dissertation, The City University of New York.
Evans, A. S., and Kraus, G., 1978, Immunization against swine influenza in the Yale University community, Yale J. Biol. Med. 51:165–176.
Fedson, D. S., and Kessler, H. A., 1983, A hospital-based influenza immunization program, 1977–78, Am. J. Public Health 73:442–445.
Felix, J. K., Schwartz, R. H., and Myers, G. J., 1976, Isolated hypoglossal nerve paralysis following influenza vaccination, Am. J. Dis. Child. 130:82–83.
Fell, P. J., O’Donnell, H. F., Watson, N. P., et al., 1977, Longer term effects of live influenza vaccine in patients with chronic pulmonary disease, Lancet 1:1282–1284.
Foy, H. M., Cooney, M., McMahan, R., et al., 1969, A field trial of Hong Kong-strain influenza vaccine in Seattle schoolchildren, Bull WHO 41:564–566.
Francis, T., Pearson, H. E., Salk, J. E., et al., 1944, Immunity in human subjects artificially infected with influenza virus, type B, Am. J. Public Health 34:317–334.
Frank, A. L., Webster, R. G., Glezen, W. P., et al., 1981, Immunogenicity of influenza A/USSR (H1N1) subunit vaccine in unprimed young adults, J. Med. Virol 7:135–142.
Ganz, P. A., Shanley, J. D., and Cherry, J. D., 1978, Responses of patients with neoplastic diseases to influenza virus vaccine, Cancer 42:2244–2247.
Gaydos, J. C., Hodder, R. A., Top, F. H., et al., 1977a, Swine influenza at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases, J. Infect. Dis. 136:S356–S362.
Gaydos, J. C., Hodder, R. A., Top, F. H., et al., 1977b, Swine influenza at Fort Dix, New Jersey (January-February 1976). II. Transmission and morbidity in units with cases, J Infect. Dis. 136:S363–S375.
Ghendon, Y. Z., Polezhaev, F. I., Lisovskaya, K. V., et al., 1984, Recombinant cold-adapted attenuated influenza A vaccines for use in children: Molecular genetic analysis of the cold-adapted donor and recombinants, Infect. Immun. 44:730–733.
Goldfield, M., Bartley, J. D., Pizzuti, W., et al., 1977, Influenza in New Jersey in 1976: Isolations of influenza A/New Jersey/76 virus at Fort Dix, J. Infect. Dis. 136:S347–S355.
Gomolin, I. H., Chapron, D. J., and Luhan, P. A., 1985, Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly, J. Am. Geriatr. Soc. 33:269–272.
Goodeve, A., Potter, C. W., Clark, A., et al., 1983, A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: Reactogenicity, antibody response and protection to challenge virus infection, J. Hyg. (Camb.) 90:107–115.
Goodeve, A. C., Jennings, R., and Potter, C. W., 1985, Reassortants of influenza B viruses for use in vaccines: An evaluation, Arch. Virol. 83:169–179.
Graves, P. N., Schulman, J. L., Young, J. F., et al., 1983, Preparation of influenza virus subviral particles lacking the HAl subunit of hemagglutinin: Unmasking of cross-reactive HA2 determinants, Virology 126:106–116.
Green, N., Alexander, H., Olson, A., et al., 1982, Immunogenic structure of the influenza virus hemagglutinin, Cell 28:477–487.
Greenstreet, R. L., 1984, Estimation of the probability that Guillain-Barre syndrome was caused by the swine flu vaccine: U.S. experience (1976–1977), Med. Sci. Law 24:61–67.
Gremillion, D. H., Meiklejohn, G., Graves, P., et al., 1983, Efficacy of single-dose influenza immunization in Air Force recruits,J. Infect. Dis. 147:1099.
Gross, P. A., 1977, Reactogenicity and immunogenicity of bivalent influenza vaccine in one-and two-dose trials in children: A summary, J. Infect. Dis. 136:S616–S625.
Gross, P. A., Ennis, F. A., Gaerlan, P. F., et al., 1981, Comparison of new triton X-100 and tween-ether-treated split-product vaccines in children, J. Clin. Microbiol. 14:534–538.
Gross, P. A., Gould, A. L., and Brown, A. E., 1985, Effect of cancer chemotherapy on the immune response to influenza virus vaccine: Review of published studies, Rev. Infect. Dis. 7:613–618.
Grossebauer, K., Langmaack, H., Schmidt, B., et al., 1969, Enhancement and neutralization of pyroge-nicity of influenza viruses by biologically active substances, Arch. Ges. Virusforsch. 28:151–164.
Gwaltney, J. M., DeSanctis, A. N., Metzgar, D. P., et al., 1977, Systematic reactions to influenza B vaccine. Am. J. Epidemiol. 105:252–260.
Hackett, C. J., Taylor, P. M., and Askonas, B. A., 1983, Stimulation of cytotoxic T cells by liposomes containing influenza virus or its components, Immunology 49:255–263.
Hackett, C. J., Hurwitz, J. L., Dietzschold, B., et al., 1985, A synthetic decapeptide of influenza virus hemagglutinin elicits helper T cells with the same fine recognition specificities as occur in response to whole virus, J. Immunol. 135:1391–1394.
Hall, W. J., Douglas, R. G., Jr., Zaky, D. A., et al., 1976, Attenuated influenza virus in normal adults: Role of pulmonary function studies in vaccine trials, J. Infect. Dis. 133:145–152.
Halperin, W., Weiss, W. I., Altman, R., et al., 1979, A comparison of intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: Report of a study and review of the literature, Am. J. Public Health 69:1247–1251.
Hamzawi, J., Jennings, R., and Potter, C. W., 1981, Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses, J. Hyg. (Camb.) 87:453–464.
Hasselbacher, P., 1977, Neuropathy after influenza vaccination, Lancet 1:551–552.
Helenius, A., and Simons, K., 1975, Solubilization of membranes by detergents, Biochim. Biophys. Acta 415:29.
Henle, W., and Henle, G., 1945, Effects of adjuvants on vaccination of human beings against influenza, Proc. Soc. Exp. Biol. Med. 59:179–181.
Herbert, A. A., Larke, R. P. B., and Markstad, E. L., 1979, Comparison of responses to influenza A/New Jersey/76-A/Victoria/75 virus vaccine administered intradermally or subcutaneously to adults with chronic respiratory disease, J. Infect. Dis. 140:234–238.
Higashihara, M. 1975, Studies on genetic recombinants of influenza virus, Kitasato Arch. Exp. Med. 48:183–188.
Hilleman, M. R., 1966, Critical appraisal of emulsified oil adjuvants applied to viral vaccines in: Progress in Medical Virology ,Volume 8 (J. L. Melnick, ed.), S. Karger, Basel, pp. 131–182.
Hilleman, M. R., 1977, Serologic responses to split and whole swine influenza virus vaccines in light of the next influenza pandemic, J. Infect. Dis. 136:S683–S685.
Hirst, G. K., Rickard, E. R., Whitman, L., et al., 1942, Antibody response of human beings following vaccination with influenza viruses, J. Exp. Med. 75:495–511.
Hodder, R. A., Gaydos, J. C., Allen, R. G., et al., 1977, Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak, J. Infect. Dis. 136:S369–S375.
Hodges, G. R., Davis, J. W., Lewis, D., et al., 1979, Response to influenza A vaccine among high-risk patients, South. Med. J. 72:29–32.
Hoskins, T. W., 1977, Systemic reactions to influenza vaccine containing killed influenza A/.New Jersey/8/76, Practitioner 219:400–401.
Hoskins, T. W., Davies, J. R., Allchin, A., et al., 1973, Controlled trial of inactivated influenza vaccine containing the A/Hong Kong strain during an outbreak of influenza due to the A/England/42/72 strain, Lancet 2:116–120.
Hoskins, T. W., Davies, J. R., Smith, A. J., et al., 1979, Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ’s Hospital, Lancet 1:33–35.
Houston, T. P., 1983, Small-vessel vasculitis following simultaneous influenza and pneumococcal vaccination, N.Y. State J. Med. 83:1182–1183.
Hruskova, J., Syrucek, L., Zaradova, H., et al., 1978, Secretory antibody response to haemagglutinin of influenza virus A/Swine and A/Victoria in humans after administration of split and whole-virion vaccine, J. Biol. Stand. 6:181–185.
Hurwitz, E. S., Schonberger, L. B., Nelson, D. B., et al., 1981, Guillain-Barre syndrome and the 1978–1979 influenza vaccine, N. Engl. J. Med. 304:1557–1561.
Infectious Disease Branch, NIAID, 1976, Memo: Immunizations to protect individuals working with influenza virus, April 28, NIH, Bethesda.
Iwasaki, T., and Nozima, T., 1977, Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production, J. Immunol. 118:256–263.
Jennings, R., and Potter, C. W., 1973, Enhanced response to influenza A vaccines in hamsters primed by prior heterotype influenza infection, Arch. Ges. Virusforsch. 42:197–206.
Jennings, R., Smith, T. L., Spencer, R. C., et al., 1984, Inactivated influenza virus vaccines in man: A comparative study of subunit and split vaccines using two methods for assessment of antibody responses, Vaccine 2:75–80.
Jennings, R., Smith, T. L., Mellersh, A. R., et al., 1985, Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine, J. Hyg. (Camb.) 94:87–95.
Johannsen, R., Moser, H., Hinz, J., et al., 1983, The quantification of the haemagglutinin content of influenza whole virus and Tween-ether split vaccines,J. Biol. Stand. 11:341–352.
Johnson, P. R., Feldman, S., Thompson, J. M., et al., 1985, Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine, J. Med. Virol. 17:325–335.
Journal of the American Medical Association ,1984, AMA offers recommendations for vaccine injury compensation, J.A.M.A. 252:2937–2946.
Kaplan, J. E., Katona, P., Hurwitz, E. S., et al., 1982, Guillain-Barre syndrome in the United States, 1979–1980 and 1980–1981, J.A.M.A. 248:698–700.
Kasel, J. A., Six, H. R., Couch, R. B., et al., 1979, Variant-specific antihemagglutinin serum response to type A influenza natural infection and inactivated vaccines in adults, Proc. Soc. Exp. Biol. Med. 161:519–521.
Kava, T., and Laitinen, L. A., 1985, Effects of killed and live attenuated influenza vaccine on symptoms and specific airway conductance in asthmatics and healthy subjects, Allergy 40:42–47.
Kavet, J., 1972, Influenza and Public Health ,Masters thesis, Harvard School of Public Health, Boston.
Kavet, J., 1976, Vaccine utilization: Trends in the implementation of public policy in the U.S.A., in: Influenza: Virus Vaccines Strategy (P. Selby, ed.), Academic Press, New York, pp. 297–308.
Kendal, A. P., Goldfield, M., Noble, G. R., 1977a, Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey, J. Infect. Dis. 136:S381–S385.
Kendal, A. P., Noble, G. R., and Dowdle, W., 1977b, Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunological primed and unprimed populations, J. Infect. Dis. 136:S415–424.
Khan, M. W., Gallagher, M., Bucher, D., et al., 1982, Detection of influenza virus neuraminidase-specific antibodies by an enzyme-linked immunosorbent assay, J. Clin. Microsc. 16:115–122.
Kilbourne, E. D., 1969, Future influenza vaccines and the use of genetic recombinants, Bull WHO 41:643–645.
Kilbourne, E. D., 1976a, Op-ed page, New York Times ,February 13, p. 33.
Kilbourne, E. D., 1976b, Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in the induction of anti-neuraminidase antibody in man, J. Infect. Dis. 134:384–394.
Kilbourne, E. D., 1977, Influenza pandemics in perspective, J.A.M.A. 237:1225–1228.
Kilbourne, E. D., 1978, Opinion: Influenza as a problem in immunology, J. Immunol. 120:1447–1452.
Kilbourne, E. D., 1979, Swine flu: The virus that vanished, Human Nature 2:68–73.
Kilbourne, E. D., 1984, Immunization strategy: Infection-permissive vaccines for the modulation of infection, in: Modern Approaches to Vaccines (R. M. Chanock and R. A. Lerner, eds.), Cold Spring Harbor Laboratory, New York, pp. 269–274.
Kilbourne, E. D., 1985, Problems inherent in artificial immunization, Microbiology-1985, 243–246.
Kilbourne, E. D., and Murphy, J. S., 1960, Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8. J. Exp. Med. 111:387–406.
Kilbourne, E. D., Laver, W. G., Schulman, J. L., et al., 1968, Antiviral activity of antiserum specific for an influenza virus neuraminidase. I. In vitro effects, J. Virol. 2:281–288.
Kilbourne, E. D., Schulman, J. L., Schild, G. C., et al., 1971, Correlated studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J. Infect. Dis. 124:449–462.
Kilbourne, E. D., Chanock, R. M., Choppin, P. W., et al., 1974, Influenza vaccine: summary of influenza workshop V, J. Infect. Dis. 129:770–771.
Kilbourne, E. D., McGregor, S., and Easterday, B. C., 1981, Transmission of swine of hemagglutinin mutants of swine influenza virus, in: The Replication of Negative Strand Viruses (D. H. Bishop and R. W. Compans, eds.), Elsevier/North Holland, Amsterdam, pp. 449–453.
Kilbourne, E. D., Gerhard, W., and Whitaker, C. W., 1983, Monoclonal antibodies to the hemagglutinin Sa antigenic site of A/PR/8/23 influenza virus distinguish biologic mutants of swine influenza virus, Proc. Natl. Acad. Sci. U.S.A. 80:6996–7000.
Klimov, A., Ghendon, Y., Zavadova, H., et al., 1983, High reproduction capacity of recombinants between H3N2 human influenza and fowl plague viruses is due to the gene coding for M proteins, Acta Virol. 27:434–438.
Kramer, P., and McClain, C. J., 1981, Depression of aminopyrine metabolism by influenza vaccination, N Engl. J. Med. 305:1262–1264.
Kramer, P., Tsuru, M., Cook, C. E., et al., 1984, Effect of influenza vaccine on warfarin anticoagulation, Clin. Pharmacol. Ther. 35:416–418.
Kreuter, J., Mauler, R., Gruschkau, H., et al., 1976, The use of new polymethylmethacrylate adjuvants for split influenza vaccines, Exp. Cell Biol. 44:12–19.
Kuwert, E. K., Werner, J., Scheiermann, N., et al., 1979, Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza. I. Hemagglutination inhibiting antibodies. Zentralbl. Bakteriol. Hyg. 244:155–174.
Lamb, J. R., Eckels, D. D., Lake, P., et al., 1982, Human T-cell clones recognize chemically synthesized peptides of influenza hemagglutinin, Nature 300:66–69.
La Montagne, J. R., Noble, G. R., Quinnan, G. V., et al., 1983, Summary of clinical trials of inactivated influenza vaccine-1978, Rev. Infect. Dis. 5:723–736.
Lang, G., 1981, Turkey influenza vaccination. Vet. Rec. 108:425.
Langmuir, A. D., 1979, Guillain-Barre syndrome: The swine influenza virus vaccine incident in the United States of America, 1976–77: Preliminary communication, J. R. Soc. Med. 72:660–669.
Langmuir, A. D., Bregman, D. J., Kurland, L. T., et al., 1984, An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines,J. Epidemiol. 119:841–879.
Lazzell, V., Waldman, R. H., Rose, C., 1984, Immunization against intluenza in humans using an oral enteric-coated killed virus vaccine, J. Biol. Stand. 12:315–321.
Leibovitz, A., Coultrip, R. L., Kilbourne, E. D., et al., 1971, Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees, J. Infect. Dis. 124:481–487.
Lerman, S. J., Wright, P. F., and Patil, K. D., 1980, Antibody decline in children following A/New Jersey/76 influenza virus immunization, J. Pediatr. 96:271–274.
Levine, M., Jones, M. W., and Gribble, M., 1984, Increased serum phenytoin concentration following influenza vaccination, Clin. Pharm. 3:505–509.
Lyons, J. E., 1976, The manufacturers’ role in the preparation of swine flu vaccine, in: Meeting of the New Jersey Public Health Association, June 23, Fort Dix, N.J.
Maassab, H. F., 1967, Adaptation and growth characteristics of influenza virus at 25°C, Nature 213:612–614.
Maassab, H. F., Monto, A. S., and DeBorde, D. C., et al., 1981, Development of cold recombinants of influenza virus as live virus vaccines, in: Genetic Variation among Influenza Viruses (D. P. Nayak, ed.), ICN-UCLA Symposia on Molecular and Cellular Biology ,Vol. XXI, Academic Press, New York, pp. 617–637.
Maassab, H. R., Kendal, A. P., Abrams, G. D., et al., 1982, Evaluation of a cold-recombinant influenza virus vaccine in ferrets, J. Infect. Dis. 146:780–790.
MacKenzie, J. S., 1977, Influenza subunit vaccine: Antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly, Br. Med. J. 1:200–202.
Macoul, K. L., 1982, Bilateral optic nerve atrophy and blindness following swine influenza vaccination, Ann. Ophthalmol. 14:398–399.
MacPherson, B. V., Ashikaga, T., Dennis, S. M., et al., 1980, A cohort study of preventive health behavior: Swine flu vaccination acceptance in Vermont, Del. Med. J. 52:427–432.
Marine, W. M., and Stuart-Harris, C., 1976, Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine, J. Pediatr. 88:26–30.
Marine, W. M., and Thomas, J. E., 1979, Antigenic memory to influenza A viruses in man determined by monovalent vaccines, Postgrad. Med. J. 55:98–108.
Massicot, J. G., Murphy, B. R., Thierry, F., et al., 1980a, Temperature-sensitive mutants of influenza virus, Virology 101:242–249.
Massicot, J. G., Murphy, B. R., Van Wyke, K., et al., 1980b, P1 and P3 genes are responsible for satisfactory level of attenuation of ts-142 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus, Virology 106:187–190.
Masurel, N., Ophof, P., and dejong, P., 1981, Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus, J. Hyg. (Camb.) 87:201–209.
Matzkin, H., and Nili, E., 1984, Accidental tenfold overdose of influenza A vaccine: A clinical and serological study, Isr. J. Med. Sci. 20:411–415.
McCahon, D., and Schild, G. C., 1972, Segregation of antigenic and biological characteristics during influenza virus recombination, J. Gen. Virol. 15:73–77.
McCarroll, J. R., and Kilbourne, E. D., 1958, The equivalence of the subcutaneous and intradermal routes in immunization with Asiatic strain influenza vaccine, N. Engl. J. Med. 259:618–621.
McDonald, J. C., Zuckerman, A. J., Beare, A. S., et al., 1962, Trials of live influenza vaccine in the Royal Air Force, Br. Med. J. 1:1036–1042.
McLaren, C., Potter, C. W., and Jennings, R., 1974, Immunity to influenza in ferrets, Med. Microbiol. Immunol. 160:33–45.
McLean, I. W., Jr., Beard, D., Taylor, A. R., et al., 1945, The relation of antibody response in swine to dose of the swine influenza virus inactivated with formalin and with ultraviolet light, J. Immunol. 51:65–99.
McMichael, A. J., Gotch, F., Cullen, P., et al., 1981, The human cytotoxic T cell response to influenza A vaccination, Clin. Exp. Immunol. 43:276–284.
McMichael, A. J., Askonas, B. A., Webster, R. G., et al., 1982, B-cell or T-cell immunity? Immunol. Today 3:255–260.
Meiklejohn, G., 1958, Effectiveness of monovalent influenza A-prime vaccine during 1957 influenza A-prime epidemic, Am. J. Hyg. 67:237–249.
Meiklejohn, G., 1961, Asian influenza vaccination: Dosage, routes, schedules of inoculation and reactions, Am. Rev. Respir. Dis. 83:175–177.
Meiklejohn, G., Eickhoff, T. C., Graves, P., et al., 1978, Antigenic drift and efficacy of influenza virus vaccines, 1976–1977, J. Infect. Dis. 138:618–624.
Melchizedek, A. N., Wabuke-Bunoti, Taku, A., et al., 1984, Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin, J. Immunol. 133:2194–2201.
Meredith, C. G., Christian, C., Johnson, R. F., et al., 1985, Effects of influenza virus vaccine on hepatic drug metabolism, Clin. Pharmacol. Ther. 37:396–401.
Mihail, A., Popa, L. M., Petrescu, A., et al., 1981, Study of recombinants derived from autochthonous influenza virus type A strains, Rev. Roum, Med. Virol. 32:225–229.
Miles, R., Potter, C. W., Clarke, A., et al., 1982, A comparative study of the reactogenicity and im-munogenicity of two inactivated influenza vaccines in children, J. Biol. Stand. 10:59–68.
Mills, J., and Chanock, R. M., 1971, Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals, J. Infect. Dis. 123:145–157.
Mitchell, D. M., Fitzharris, P., Knight, R. A., et al., 1982, Kinetics of specific in vitro antibody production following influenza immunization, Clin. Exp. Immunol. 48:491–498.
Monto, A. S., and Ross, H. W., 1979, Swine influenza vaccine program in the community: Acceptability, reactions and responses, Am. J. Public Health 69:233–237.
Monto, A. S., Miller, F. D., and Maassab, H. F., 1982, Evaluation of an attenuated, cold-recombinant influenza B virus vaccine, J. Infect. Dis. 145:57–64.
Morein, B., and Simons, K., 1985, Subunit vaccines against enveloped viruses: Virosomes, micelles and other protein complexes, Vaccine 3:83–93.
Mostow, S. R., Schoenbaum, S. C., Dowdle, W. R., et al., 1970, Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man, Am. J. Epidemiol. 92:248–256.
Mostow, S. R., Dowdle, W. R., Schoenbaum, S. C., et al., 1973, Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation, Postgrad. Med. J. 49:152–158.
MRC Advisory Group on Pulmonary Function Tests in Relation to Live Influenza Vaccines, 1984, Trials of live attenuated influenza virus vaccine in patients with chronic obstructive airways disease, Br. J. Dis. Chest 78:236–247.
Muldoon, R. L., Stanley, E. D., and Jackson, G. G., 1976, Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A, Am. Rev. Respir. Dis. 113:487–491.
Mumford, J., Wood, J. M., Scott, A. M., et al., 1983, Studies with inactivated equine influenza vaccine, J. Hyg. (Camb.) 90:385–395.
Murphy, B. R., and Chanock, R. M., 1985, Immunization against viruses, in: Virology (B. N. Fields, ed.), Raven Press, New York, pp. 349–370.
Murphy, B. R., Chalhub, E. G., Nusinoff, S. R., et al., 1972, Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man, J. Infect. Dis. 126:170–178.
Murphy, B. R., Chalhub, E. G., Nusinoff, S. R., et al., 1973, Temperature sensitive mutants of influenza virus. III. Further characterization of the ts-l[E] influenza A recombinant, J. Infect. Dis. 128:479–487.
Murphy, B. R., Richman, D. D., Spring, S. B., et al., 1976, Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains: Evaluation in laboratory animals, adults and children, Postgrad. Med. 52:381–388.
Murphy, B. R., Markoff, L. J., Chanock, R. M., et al., 1980, Genetic approaches to attenuation of influenza A viruses for man, Phil. Trans. R. Soc. Lond. [Biol] 288:401–415.
Murphy, B. R., Buckler-White, A. J., London, W. T., et al., 1984, Avian-human reassortant influenza A viruses derived from mating avian and human influenza A viruses, J. Infect. Dis. 150:841–850.
Murphy, K. R., and Strunk, R. C., 1985, Safe administration of influenza vaccine in asthmatic children sensitive to egg proteins, J. Pediatr. 106:931–933.
Murray, D. L., Imagawa, D. T., Kada, D. M., et al., 1979, Antibody response to nonvalent A/New Jersey/8/76 influenza vaccine in pregnant women, J. Clin. Microbiol. 10:184–187.
Murray, R., 1961, Some problems in the standardization and control of influenza vaccine in 1957, Am. Rev. Respir. Dis. 83:160–167.
Nature ,1985, Editorial: Statutory compensation urged, 316:476–477.
Nestorowicz, A., Tregear, G. W., Southwell, C. N., et al., 1985, Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites, Mol Immunol. 22:145–154.
Neustadt, R. E., and Fineberg, H. V., 1978, The Swine Flu Affair, Decision Making on a Slippery Disease. U. S. Department of HEW, Washington.
Newton Dunn, G. F., and Wormald, P. J., 1973, Influenza A Hong Kong vaccine and the new variant A/Eng/42/72, Lancet 1:95.
Noble, G. R., Kaye, H. S., Kendal, A. P., et al., 1977, Age-related heterologous antibody responses to influenza virus vaccination, J. Infect. Dis. 136:S686–692.
Odagiri, T., DeBorde, D. C., and Maassab, H. F., 1982, Cold-adapted recombinants of influenza A virus in MDCK cells. I. Development and characterization of A/Ann Arbor/6/60x A/Alaska/6/77 recombinant viruses, Virology 119:82–95.
Odagiri, T., Smitka, C. W., and Maassab, H. G., 1983, Cold-adapted reassortants of influenza A virus in MDCK cells. II. Role of the temperature-sensitive property of cold-adapted reassortants in mice, Microbiol. Immunol. 27:203–206.
O’Donoghue, J. M., Ray, C. G., Terry, D. W., Jr., et al., 1973, Prevention of nosocomial influenza infection with amantadine, Am. J. Epidemiol. 97:276–282.
Ogra, P. L., Chow, T., Beutner, K. R., et al., 1977, Clinical and immunologic evaluation of neur-aminidase-specific influenza A virus vaccine in humans, J. Infect. Dis. 135:499–506.
Okuno, Y., and Nakamura, K., 1966, Prophylactic effectiveness of live influenza vaccine in 1965, Biken J. 9:89–95.
Osborn, J. (ed.), 1977, Influenza in America, 1918–1976 9,Prodist, New York.
Palese, P., and Schulman, J. L., 1976, RNA pattern of “swine” influenza virus isolated from man is similar to those of other swine influenza viruses, Nature 263:528–530.
Panicali, D., Davis, S. W., Weinberg, R. L., et al., 1983, Construction of live vaccines by using genetically engineered poxviruses: Biological activity of recombinant vaccinia virus expressing influenza virus haemagglutinin, Proc. Natl. Acad. Sci. U.S.A. 80:5364.
Paoletti, E., Weinberg, R. L., Davis, S. W., et al., 1984, Genetically engineered poxviruses: A novel approach to the construction of live vaccines, Vaccine 2:204–205.
Parkman, P. D., Hopps, H. E., Rastogi, S. C., et al., 1977, Summary of clinical trials of influenza virus vaccines in adults, J. Infect. Dis. 136:S722–730.
Patriarca, P. A., Kendal, A. P., Stricof, R. L., et al., 1983, Influenza vaccination and warfarin or theophylline toxicity in nursing-home residents, N. Engl. J. Med. 308:1601–1602.
Patriarca, P. A., Kater, N. A., Kendal, A. P., et al., 1984, Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes, An-timicrob. Agents Chemother. 26:101–103.
Patriarca, P. A., Weber, J. A., Parker, R. A., et al., 1985, Efficacy of influenza vaccine in nursing homes, J.A.M.A. 253:1136–1139.
Payler, D. K., and Purdham, P. A., 1984, Influenza A prophylaxis with amantadine in a boarding school, Lancet 1:502–504.
Pearman, W. A., 1978, Participation in flu immunization projects: What can we expect in the future? Am. J. Public Health 68:674–675.
Pemberton, R. M., Jenning, R., and Smith, T. L., 1985, Morphology and antigenicity studies on reas-sortant influenza (H3N2) viruses for use in inactivated vaccines, J. Hyg. (Camb.) 94:229–239.
Perkins, F. T., 1972, Experience in the United Kingdom with oil adjuvant influenza vaccines, Ann. Allergy 30:288–291.
Perry, H. D., Mallen, F. J., Grodin, R. W., et al., 1979, Reversible blindness in optic neuritis associated with influenza vaccination, Ann. Ophthalmol. 11:545–550.
Petrescu, A., Cajal, N., Bronitki, A., et al., 1977, The experience of the Stefan S. Nicolau Institute of Virology in the preparation and administration of inactivated influenza vaccines applicable by nasal or oral route, Rev. Roum. Med. Virol. 28:213–217.
Petrov, R. V., Zhdanov, V. M., Kabanov, V. A., et al., 1985, [Enhancement of the immune response to surface antigens of influenza virus as a result of their covalent binding with a synthetic carrier polymer], Biull. Eksp. Biol. Med. 99:184–186.
Phillips, C. A., Forsyth, B. R., Christmas, W. A., et al., 1970, Purified influenza vaccine: Clinical and serologic responses to varying doses and different routes of immunization, J. Infect. Dis. 122:26–32.
Poser, C. M., Roman, G., and Emery, E. S. III, 1978, Recurrent disseminated vasculomyelinopathy, Arch. Neurol 35:166–170.
Potter, C. W., Oxford, J. S., Shore, S. L., et al., 1972, Immunity to influenza in ferrets. I. Response to live and killed virus, Br. J. Exp. Pathol. 53:153–167.
Powers, R. D., Hayden, F. G., Samuelson, J., et al., 1984, Immune response of adults to sequential influenza vaccination, J. Med. Virol. 14:169–175.
Quarles, J. M., Couch, R. B., Cate, T. R., et al., 1981, Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza, Antivir. Res. 1:149–155.
Quinnan, G. V., Schooley, R., Dolin, R., et al., 1983, Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines, Rev. Infect. Dis. 5:748–757.
Ratner, E. R., and Fedson, D. S., 1983, Influenza and pneumococcal immunization in medical clinics, 1978–1980, Arch. Intern. Med. 143:2066–2069.
Reeve, P., Pibermann, M., Bachmayer, H., et al., 1982, Studies in man with a cold-recombinant live influenza B virus vaccine, J. Med. Virol. 9:1–9.
Reiss, C. S., and Schulman, J. L., 1980, Cellular immune responses of mice to influenza virus vaccines,J.. Immunol. 125:2182–2188.
Renton, K. W., Gray, J. D., and Hall, R. I., 1980, Decreased elimination of theophylline after influenza vaccination, Can. Med. J. 123:288–290.
Riddiough, M. A., Sisk, J. E., and Bell, J. C., 1983, Influenza vaccination. Cost-effectiveness and public policy, J.A.M.A. 249:3189–3195.
Rodda, S. J., Gallichio, H. A., and Hampson, A. W., 1981, The single radial immunodiffusion assay highlights small antigenic differences among influenza virus hemagglutinins, J. Clin. Microbiol. 14:479–482.
Rogers, G. N., Daniels, R. S., Skehel, J. J., et al., 1985, Host-mediated selection of influenza virus receptor variants, J. Biol. Chem. 260:7362–7367.
Rose, H. J., 1980, The use of amantadine and influenza vaccine in a type A influenza epidemic in a boarding school, J. R. Coll. Gen. Pract. 30:619–621.
Rosen, C. M., Roman, G., and Emery, E. S. III, 1978, Recurrent disseminated vasculomyelinopathy, Arch. Neurol. 35:166–170.
Rosenzweig, D. Y., Dwyer, D. J., Ferstenfeld, J. E., et al., 1975, Changes in small airway function after live attenuated influenza vaccination, Am. Rev. Respir. Dis. 111:399–403.
Rott, R., Becht, H., and Oflich, M., 1974, The significance of influenza virus neuraminidase in immunity, J. Gen. Virol 22:35–41.
Ruben, F. L., Potter, C. W., and Stuart-Harris, C. H,, 1975, Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine, Arch. Virol 47:157–166.
Rytel, M. W., Jackson, L. J., Ferstenfeld, J. E., et al., 1975, New live attenuated influenza A/En-gland/42/72JH3N2) vaccine (“Alice”) reactogenicity, immunogenicity, and protection efficacy, J. Infect. Dis. 132:652–659.
Sabin, A. B., 1977, Swine flu: What happened. Sciences 17:14–30.
Salk, J. E., 1948, Reactions to concentrated influenza vaccines, J. Immunol. 58:369–395.
Salk, J. E., Bailey, M. L., and Laurent, A. M., 1952, The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water-in-oil emulsion, Am. J. Hyg. 55:439.
Schiff, G. M., Linnemann, C. C., Shea, L., et al., 1975, Evaluation of a live, attenuated recombinant influenza vaccine in high school children, Infect. Immun. 11:754–757.
Schoenbaum, S. C., 1979, Influenza vaccine-unacceptable or unaccepted, Am. J. Public Health 69:219–221.
Schoenbaum, S. C., McNeil, B. J., and Kavet, J., 1976, The swine-influenza decision, N. Engl. J. Med. 295:759–765.
Scholtissek, C., Vallbracht, A., Flehmig, B., et al., 1979, Correlation of pathogenicity and gene constellation of influenza A viruses. II. Highly neurovirulent recombinants derived from non-neurovirulent or weakly neurvirulent parent virus strains, Virology 95:492–500.
Schonberger, L. B., Bregman, D. J., Sullivan-Bolyai, J. Z., et al., 1979, Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977, Am. J. Epidemiol 110:105–123.
Schulman, J. L., 1967, Experimental transmission of influenza virus infection in mice. III. Differing effects of immunity induced by infection and by inactivated influenza virus vaccine on transmission of infection, J. Exp. Med. 125:467–478.
Schulman, J. L., 1975, Immunology of influenza, in: The Influenza Viruses and Influenza (E. D. Kilbourne, ed.), Academic Press, New York, pp. 373–390.
Schulman, J. L., and Kilbourne, E. D., 1971, Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals, J. Infect. Dis. 124:463–472.
Schulman, J. L., and Palese, P., 1978, Biological properties of recombinants of A/Hong Kong and A/PR8 viruses: Effects of genes for matrix protein and nucleoprotein in virus yield in embryonated eggs, in: Negative Strand Viruses and the Host Cell (B. W. J. Mahy and R. D. Barry, eds.), Academic Press, New York, pp. 663–674.
Schulman, J. L., Khakpour, M., and Kilbourne, E. D., 1968, Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice, J. Virol. 2:778–786.
Schutze, M.-P., Lerclerc, C., Jolivet, M., et al., 1985, Carrier-induced epitopic suppression, a major issue for future synthetic vaccines, J. Immunol. 135:2319–2322.
Serie, C., Barme, M., Hannoun, C., et al., 1977, Effects of vaccination on an influenza epidemic in a geriatic hospital, Dev. Biol. Stand. 39:317–321.
Seyal, M., Ziegler, D. K., and Couch, J. R., 1978, Recurrent Guillain-Barre syndrome following influenza vaccine, Neurology (Minneap.) 28:725–726.
Shapira, M., Jibson, M., Muller, G., et al., 1984, Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin, Proc. Natl. Acad. Sci. U.S.A. 81:2461–2465.
Sheps, S. B., Mathias, R. G., Wilson, R., et al., 1985, Influenza vaccine utilization in a metropolitan health department: supply side constraints, Can. J. Public Health 76:378–383.
Shore, S. L., Potter, C. W., and Stuart-Harris, C. H., 1973, Antibody response to inactivated influenza vaccine given by different routes in patients with chronic bronchopulmonary disease, Thorax 28:721–728.
Siegert, R., and Braune, P., 1964, The pyrogens of myxoviruses. II. Resistance of influenza A pyrogens to heat, ultraviolet and chemical treatment, Virology 24:218–224.
Silverstein, A. M., 1981, Pure Politics and Impure Science ,The Johns Hopkins University Press, Baltimore, London.
Slepushkin, A. N., Ellengorn, N. S., Russina, A. E., et al., 1968, Assessment of the efficacy of mass influenza vaccinations. [Assessment of the efficacy of mass influenza vaccinations. Report II], (English summary), J. Microbiol. Epidemiol. Immunobiol. 10:26–32.
Smith, G. L., Murphy, B. R., and Moss, B., 1983, Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters, Proc. Natl. Acad. Sci. U.S.A. 80:7155–7159.
Smith, J. W. G., and Pollard, R., 1979, Vaccination against influenza: A five-year study in the Post Office, J. Hyg. (Camb.) 83:157–170.
Smorodintsev, A. A., Tushinsky, M. D., Drobyshevskaya, A. I., et al., 1937, Investigation on volunteers infected with influenza virus, Am. J. Med. Sci. 194:159–170.
Smorodintsev, A. A., Mikutskaya, B. A., Alexandrova, G. I., 1967, Data on safety and epidemiological efficiency of anti-influenza vaccine studied on pre-school children, J. Hyg. Epidemiol. Microbiol. Immunol. 11:265–277.
Smorodintsev, A. A., Karpuhin, G. I., Zlydnikov, D. M., et al., 1970, The prophylactic effectiveness of amantadine hydrochloride in an epidemic of Hong Kong influenza in Leningrad in 1969, Bull. 42:865–872.
Soloviev, V. D., Orlova, T. G., Porubel, L. A., et al., 1961, Study of the genetic characters of vaccine strains of type A-2 influenza virus, Prob. Virol. 6:743–750.
Spencer, M. J., Cherry, J. D., and Terasaki, P. I., 1976, HL-A antigens and antibody response after influenza A vaccination, N. Engl. J. Med. 294:13–16.
Spring, S. B., Maassab, H. F., Kendal, A. P., et al., 1977, Arch. Virol. 55:233–246.
Steinberg, E., Overturf, G. D., Portnoy, B., et al., 1978, Serologic and clinical response of children with sickle cell disease to bivalent influenza A split virus vaccine, J. Pediatr. 92:823–825.
Steinherz, P. G., Brown, A. E., Gross, P. A., et al., 1980, Influenza immunization of children with neoplastic diseases, Cancer 45:750–756.
Stewart-Tull, D. E. S., 1985, Immunopotentiating conjugates, Vaccine 3:40–44.
Stiver, H. G., and Weinerman, B. H., 1978, Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients, Can. Med. Assoc. J. 119:733–735.
Stiver, H. G., Graves, P., Eickhoff, T. C., et al., 1973, Efficacy of “Hong Kong” vaccine in preventing “England” variant influenza A in 1972, N. Engl. J. Med. 289:1267–1271.
Storms, W. W., Dick, E. C., and Busse, W. W., 1976, Intranasal immunization with attenuated live influenza vaccine in asthma, J. Allergy Clin. Immunol. 58:284–290.
Takafuji, E. T., Johnson, D. E., and Segal, H. E., 1976, The swine antigen in previous influenza vaccines, N. Engl. J. Med. 295:1018.
Tian, S., Zhang, L., and Murphy, B. R., 1984, Characterization of the genotype and level of attenuation of an influenza A reassortant virus produced by mating the Xia-ts donor virus with AJ.Beij-ing/79 (H1N1) wild type virus, Vaccine 2:189–192.
Tian, S.-F., Buckler-White, A. J., London, W. T., et al., 1985, Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reas-sortants in squirrel monkey respiratory tract, J.. Virol. 53:771–775.
Tolpin, M. D., Massicot, J. G., Mullinix, M. G., et al., 1981, Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-lA2 recombinant during growth in vivo, Virology 112:505–517.
Tolpin, M. D., Clements, M. L., Levine, M. M., et al., 1982, Evaluation of a phenotypic revertant of the A/Alaska/77-ts-lA2 reassortant virus in hamsters and in seronegative adult volunteers: Further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-lA2 reassortant viruses, Infect. Immun. 36:645–650.
Top. F. H., Jr., and Russell, P. K., 1977, Swine influenza A at Fort Dix, New Jersey (January-February 1976), IV. Summary and speculation, J. Infect. Dis. 136:S376–S379.
van de Donk, H. J. M., de Jong, J. C., van Olderen, M. F., et al., 1984, Monoclonal antibodies for the control of influenza virus vaccines, Dev. Biol. Stand. 57:251–255.
Versluis, D. J., Beyer, W. E. P., Masurel, N., et al., 1985, Influenza vaccination in dialysis and transplant patients, Antiviral Res. (Suppl.) 1:289–292.
Wabuke-Bunoti, M. A. N., Taku, A., Fan, D. P., et al., 1984, Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin, J. Immunol. 133:2194–2201.
Wagner, R. R., Bennett, I. L., Jr., and LeQuire, V. S., 1949, The production of fever by influenzal viruses. I. Factors influencing the febrile response to single injections of virus, J. Exp. Med. 90:321–334.
Waldman, R. H., Mann, J. J., and Small, P. A., Jr., 1969a, Immunization against influenza, J.A.M.A. 207:520–524.
Waldman, R. H., Bond, J. O., Levitt, L. P., et al., 1969b, An evaluation of influenza immunization, Bull. WHO 41:543–548.
Waldman, R. H., Wood, S. H., Torres, E. J., et al., 1970, Influenza antibody response following aerosol administration of inactivated virus, Am. J. Epidemiol. 94:575–584.
Waksman, B. H., and Adams, R. D., 1955, Allergic neuritis: An experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants, J. Exp. Med. 102:213–235.
Warburton, M. F., Jacobs, D. S., Langsford, W. A., et al., 1972, Herd immunity following subunit influenza vaccine administration, Med. J. Aust. 2:67–70.
Watson, W. H., Parks, M., Porter, D. A., et al., 1972, Influenza vaccination in schoolboys, Lancet 1:1336.
Webster, R. G., 1966, Original antigenic sin in ferrets: The response to sequential infections with influenza viruses, J. Immunol. 97:177–183.
Webster, R. G., and Askonas, B. A., 1980, Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice, Eur. J. Immunol. 10:396–401.
Webster, R. G., Kasel, J. A., Couch, R. B., et al., 1976, Influenza virus subunit vaccines. II. Immunoge-nicity and original sin in humans, J. Infect. Dis. 134:48–58.
Webster, R. G., Kawaoka, Y., Bean, W. J., et al., 1985, Chemotherapy and vaccination: A possible strategy for the control of highly virulent influenza virus, J. Virol. 55:173–176.
Weibel, R. E., McLean, A., Woodhour, A. F., et al., 1973, Ten-year follow-up study for safety of adjuvant 65 influenza vaccine in man, Proc. Soc. Exp. Biol. Med. 143:1053–1056.
Weintraub, M. I., and Chia, D. T. S., 1977, Paralytic brachial neuritis after swine flu vaccination, Arch. Neurol. 34:518.
Wenzel, R. P., Hendley, O., Sande, M. A. et al., 1973, Revised (1972–1973) bivalent influenza vaccine, J.A.M.A. 226:435–438.
Wesselius-de Casparis, A., Hogerzeil, H. H. W., and van Beek, A., 1973, Eleven years of experiences in industry with vaccination against influenza: Reduction in absenteeism, in: International Symposium on Influenza Vaccines for Men and Horses, London, 1972 (Symposium Series Immunobiology Standard ,Vol. 20), S. Karger, Basel, pp. 268–274.
Wiederholt, W. C., Mulder, D. W., and Lambert, E. H., 1964, The Landry Guillain-Barre-Strohl syndrome or polyradiculoneuropathy: Historical review, report on 97 patients, and present concepts, Mayo Clin. Proc. 39:427–451.
Wiley, D. C., Wilson, I. A., and Skehel, J. J., 1981, Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation, Nature 289:373–378.
Wilson, I. A., Niman, H. L., Houghten, R. A., et al., 1984, The structure of an antigenic determinant in a protein, Cell 37:767–778.
Wood, J. M., Schild, G. C., Newman, R. W., et al., 1977, An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines, J. Biol. Stand. 5:237–247.
Wood, J. M., Seagroatt, V., Schild, G. C., et al., 1981, International collaborative study of single-radial-diffusion and Immunoelectrophoresis techniques for the assay of haemagglutinin antigen of influenza virus, J. Biol. Stand. 9:317–330.
Woodhour, A. F., Friedman, A., Tytell, A. A., et al., 1969, Hyperpotentiation by synthetic double-stranded RNA of antibody responses to influenza virus vaccine in adjuvant 65, Proc. Soc. Exp. Biol. Med. 131:809–817.
World Health Organization, 1985, Recombinant vaccinia viruses as live virus vectors for vaccine antigens: Memorandum from a WHO/USPHS/NIBSC Meeting, Bull. WHO 63:471–477.
Wright, P. F., Sell, S. H. W., Thompson, J., et al., 1976, Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants, J. Pediatr. 88:31–35.
Wright, P. F., Bhargava, M., Johnson, P. R., et al., 1985, Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes, Vaccine 3:305–308.
Yamane, N., Nakamura, Y., Yuki, M., et al., 1984, Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1) in Japanese adult volunteers, J. Hyg. (Camb.) 92:231–242.
Zahradnik, J. M., Kasel, J. A., Martin, R. R., et al., 1983, Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine, J. Med. Virol. 11:277–285.
Zeck, R., Solliday, N., Kehoe, T., et al., 1976, Respiratory effects of live influenza virus vaccine: Healthy older subjects and patients with chronic respiratory disease, Am. Rev. Respir. Dis. 114:1061–1067.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1987 Edwin D. Kilbourne, M.D.
About this chapter
Cite this chapter
Kilbourne, E.D. (1987). The Control of Influenza. In: Influenza. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5239-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5239-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5241-9
Online ISBN: 978-1-4684-5239-6
eBook Packages: Springer Book Archive